Drug Discovered To Reverse Autism

HUGE: Old Drug Discovered to REVERSE AUTISM Symptoms Caused By Vaccines - SURAMIN

Published on Jun 4, 2017

Ancient Drug Discovered To Reverse Autism Symptoms Caused By Vaccines- Suramin was Developed in 1916.

Old sleeping sickness drug: Autistic 14-year-old speaks first sentence of his life - 26-05-2017

Published on May 30, 2017

Century-old sleeping sickness drug allowed an autistic 14-year-old to say the first full sentence of his life - as well as boosting sufferers' social behavior and coping skills A drug, known as suramin, produced dramatic results after just a single dose Suramin is thought to 'silence' the 'internal siren' that rings in autistic patients This allows them to focus on development, growth and healing, researchers said Improvements were made to sufferers' eye contact, interactions and playing It was developed in 1916 by German scientists for sleeping and river sickness.  Autism could be treated by a drug that has been around for more than 100 years, new research suggests.  The drug, known as suramin, which was originally developed to treat sleeping sickness, produced dramatic results in young sufferers after just one dose.  These included improvements to their language and social behavior, as well as their coping skills.  Study author Professor Robert Naviaux, from the University of California in San Diego, said: 'We had four non-verbal children in the study, two 6-year-olds and two 14-year-olds. The six-year-old and the 14-year-old who received suramin said the first sentences of their lives about one week after the single suramin infusion.'  Around one in 68 children in the US and up to one in 100 in the UK are on the autistic spectrum.  Researchers from the University of California, San Diego, administered a single dose of suramin to five male autistic children, while another five were given a placebo.  Suramin was developed by German scientists in 1916 to treat sleeping sickness and river blindness, both of which are caused by parasites.  Results, published in the Annals of Clinical and Translational Neurology, revealed that all of the patients given suramin displayed improvements in their language and social behavior, restricted or repetitive behaviors and coping skills.  Improvement was assessed according to examinations and interviews using standardized tests and questionnaires.  The researchers found ADOS-2 (Autism Diagnostic Observation Schedule, 2nd edition) scores improved by -1.6 points in the suramin group, with lowers score indicating lesser symptoms.  Changed behaviors included social communication and play, speech and language, calm and focus, repetitive behaviors, and coping skills.  The only side effect was a temporary skin rash.  A parent of a 14-year-old study participant who was given suramin and had not previously spoken a complete sentence in 12 years said: 'We saw improvements in our son after suramin that we have never seen before.  'Within an hour after the infusion he started to make more eye contact with the doctor and nurses in the room.  'There was a new calmness at times, but also more emotion at other times.  'He started to show an interest in playing hide-and-seek with his 16-year-old brother. 
Read full article here: http://www.dailymail.co.uk/health/art...   
Read also: ‘Game-changer for autism’: 100-year-old drug reverses symptoms, study finds https://www.rt.com/usa/390222-autism-... 
Read also: Researchers Studying Century-Old Drug in Potential New Approach to Autism https://health.ucsd.edu/news/releases...
Video above is: Potential autism drug needs more testing, but money is needed - Parents of autistic children who have read my recent article on suramin (j.mp/autismucsd) are asking me when the next clinical trial will begin, and how their children can apply to get into it.

‘Game Changer’ Study Finds 100 year old Drug Reverses Autism Symptoms in Kids

Published on Jun 4, 2017

http://thefreethoughtproject.com/game...

‘Game Changer’: Study Finds 100 year old Drug Reverses Autism Symptoms in Kids With just a single dose of this 100 year old drug, autistic children experienced remarkable positive cognitive and emotional improvements. Some of the children spoke their first sentences in more than a decade. This is truly a 'game changer.' According to a revolutionary new study, a drug discovered more than a century ago may hold the key to combating the symptoms of autism. After just one dose, parents of the children in the study watched their kids make incredible improvements, with some speaking for the first time. The study’s lead researcher, Dr. Robert Naviaux of the San Diego School of Medicine is an internationally known expert in human genetics, inborn errors of metabolism, metabolomics, and mitochondrial medicine. He is the discoverer of the cause of Alpers syndrome — the oldest Mendelian form of mitochondrial disease — and the developer of the first DNA test to diagnose it. Naviaux is, by far, one of the most qualified people in the world to conduct this study. During his research, Naviaux noted the transformative results of the drug suramin which was first developed in 1916 and used as an anti-parasitic drug for treating African sleeping sickness and river blindness. After giving a single dose of suramin to boys with autism, between the ages of five and 14, Naviaux recorded something incredible — their symptoms were significantly alleviated. “After the single dose, it was almost like a roadblock had been released,” he said. “If the future studies show that there’s continued health benefits, this could be a game-changer for families with autism.” The study was published in the Annals of Clinical and Translational Neurology. During the study, five children were given suramin, while the remainder were given placebos. Included in the group were four non-verbal children, two 6 year olds, and two 14 year olds. “The six-year-old and the 14 year old who received suramin said the first sentences of their lives about one week after the single suramin infusion,” Naviaux told the UC San Diego Health website. “This did not happen in any of the children given the placebo.” One parent, who noted that her son had not spoken a full sentence in more than a decade, said, “Within an hour after the infusion, he started to make more eye contact with the doctor and nurses in the room. There was a new calmness at times, but also more emotion at other times.” “He started to show an interest in playing hide-and-seek with his 16 year old brother. He started practicing making new sounds around the house. He started seeking out his dad more.” Naviaux’s expertise led him to the theory that there is a fundamental metabolic problem in all people with ASD — namely, that cells in affected people experience abnormal levels of something that Naviaux has termed the “cell danger response” (CDR), according to Seeker.